Category: Disclosures
[Disclosure] Samsung Biologics(207940) Signs KRW 88.4B (USD 63.7M) CMO Contract with European Pharmaceutical Company
[Disclosure] JUSUNG ENGINEERING (036930) Announces CEO Change; Transitions to Joint CEO Structure Leading by Founder and 2nd-Gen Successor
[Disclosure] Samsung Biologics(207940) Postpones Corporate Split Timeline: EGM Set for Oct 17, Relisting Delayed to Nov 24
[Disclosure] Samsung Biologics(207940) Amends Stock Futures & Options Final Trading Day to Oct 29 Following Revision of Restructuring Schedule
[Disclosure] HANMI Semiconductor (042700) to Attend UBS Korea Summit on Aug 26, Conducting One-on-One Closed Meetings with Global Whales on HBM4·5 & Hybrid Bonder Roadmaps